EUVIMEDEUVIMED entdecken
Crossref

Hepatotoxicity and Other Major Adverse Drug Reactions in Intensive Phase Anti-Tubercular Therapy: A Prospective Observational Study

Utkarsh Singh, Medha Bargaje, Rajeev Ranjan, Mrunmayee Yadav

International Journal of Current Pharmaceutical Review and Research · 13.05.2026 · 18 (04)

DOI: 10.25258/ijcpr.18.4.220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 13.05.2026. Verfasst von Utkarsh Singh und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anti-tubercular therapy (ATT) remains the cornerstone of tuberculosis management; however, adverse drug reactions (ADRs), particularly hepatotoxicity, pose significant challenges during the intensive phase of treatment.

Objective

To evaluate the incidence, pattern, and risk factors of hepatotoxicity and other major ADRs in patients undergoing intensive phase ATT.

Methods

This prospective observational study was conducted at Bharati Hospital, Bharati Vidyapeeth Medical College, Pune over 18 months. A total of 115 patients receiving first-line ATT were included. Patients were monitored clinically and biochemically for ADRs. Data were analyzed using appropriate statistical tests, with p < 0.05 considered significant.

Results

Hepatotoxicity was observed in 22.6% of patients. Other ADRs included gastrointestinal intolerance (18.3%), cutaneous reactions (10.4%), and neurological effects (6.1%). Significant associations were found between hepatotoxicity and age >50 years, alcohol consumption, and baseline liver enzyme elevation (p < 0.05).

Conclusion

Hepatotoxicity is a common ADR during intensive phase ATT. Early detection and regular monitoring can reduce morbidity and improve treatment adherence

Zitieren

APA

Singh, U., Bargaje, M., Ranjan, R., & Yadav, M. (2026). Hepatotoxicity and Other Major Adverse Drug Reactions in Intensive Phase Anti-Tubercular Therapy: A Prospective Observational Study. International Journal of Current Pharmaceutical Review and Research, 18(04). https://doi.org/10.25258/ijcpr.18.4.220

Vancouver

Singh U, Bargaje M, Ranjan R, Yadav M. Hepatotoxicity and Other Major Adverse Drug Reactions in Intensive Phase Anti-Tubercular Therapy: A Prospective Observational Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(04). doi:10.25258/ijcpr.18.4.220

BibTeX
@article{Singh2026,
  author = {Singh, Utkarsh and Bargaje, Medha and Ranjan, Rajeev and Yadav, Mrunmayee},
  title = {Hepatotoxicity and Other Major Adverse Drug Reactions in Intensive Phase Anti-Tubercular Therapy: A Prospective Observational Study},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {04},
  doi = {10.25258/ijcpr.18.4.220}
}
Kostenlos starten →